23.01.2017

MagForce AG presents NanoTherm™ therapy for the treatment of brain tumors at ECCO2017 from January 27-30, 2017 in Amsterdam

Berlin, Germany and Nevada, USA, January 23rd, 2017 - MagForce AG (Frankfurt, Entry Standard, XETRA: MF6, ISIN: DE000A0HGQF5), a leading medical device company in the field of nanomedicine focused on oncology, announced today its attendance at ECCO2017, the European Cancer Congress held by the ...

 

02.12.2016

MagForce AG supports NOA Winter School 2016 from December 01-02 in Münster, Germany

Berlin, Germany and Nevada, USA, December 02, 2016 - MagForce AG (Frankfurt, Entry Standard, XETRA: MF6, ISIN: DE000A0HGQF5), a leading medical device company in the field of nanomedicine focused on oncology, today announced that the Company supports NOA Winter School 2016 held by the ...

 

27.10.2016

MagForce AG participates in four upcoming international conferences in Q4 2016

Berlin, Germany and Nevada, USA, October 27, 2016 - MagForce AG (Frankfurt, Entry Standard, Xetra: MF6, ISIN: DE000A0HGQF5), a leading medical device company in the field of nanomedicine focused on oncology, today announced its participation in four upcoming scientific and investor conferences in ...

 

11.10.2016

MagForce AG publishes Directors' Dealings

download PDF

 

06.10.2016

MagForce AG publishes Directors' Dealings

download PDF